Skip to main content
. 2014 Jun 7;34(7):501–511. doi: 10.1007/s40261-014-0204-3

Table 4.

Percentage of patients taking tapentadol extended release who maintained pain control overall and by prior treatment (full analysis population)

Total
(n = 50)
Previous treatment
Morphine SR
(n = 13)
Oxycodone CR
(n = 22)
Transdermal fentanyl
(n = 15)
Patients achieving pain control, n (%) 42 (84.0) 9 (69.2) 20 (90.9) 13 (86.7)
95 % CI 70.89–92.83 38.57–90.91 70.84–98.88 59.54–98.34

CI confidence interval, CR controlled release, ER extended release, SR sustained release